Vectorcardiographic QRS area as a novel predictor of response to cardiac resynchronization therapy  by van Deursen, Caroline J.M. et al.
Available online at www.sciencedirect.com
ScienceDirect
Journal of Electrocardiology 48 (2015) 45 – 52
www.jecgonline.comVectorcardiographic QRS area as a novel predictor of response to cardiac
resynchronization therapy☆
Caroline J.M. van Deursen, MD, PhD, a, b Kevin Vernooy, MD, PhD, b Elton Dudink, MD, b
Lennart Bergfeldt, MD, PhD, c Harry J.G.M. Crijns, MD, PhD, b
Frits W. Prinzen, PhD, a,⁎ Liliane Wecke, MD, MSc, PhDd
a Cardiovascular Research Institute Maastricht, Department of Physiology, Maastricht, the Netherlands
b Cardiovascular Research Institute Maastricht, Department of Cardiology, Maastricht, the Netherlands
c Sahlgrenska Academy, Department of Molecular and Clinical Medicine/Cardiology, University of Gothenburg, Sweden
d Karolinska Institutet, Department of Cardiology, Karolinska University Hospital, Stockholm, SwedenAbstract Background: QRS duration and left bundle branch block (LBBB) morphology are used to select☆ Frits W. Prinze
MSD, EBR Systems,
Proteus Biomedical. K
Medtronic Inc. and is c





0022-0736/© 2015 Elpatients for cardiac resynchronization therapy (CRT). We investigated whether the area of the QRS
complex (QRSAREA) on the 3-dimensional vectorcardiogram (VCG) can improve patient selection.
Methods: VCG (Frank orthogonal lead system) was recorded prior to CRT device implantation in
81 consecutive patients. VCG parameters, including QRSAREA, were assessed, and compared to
QRS duration and morphology. Three LBBB definitions were used, differing in requirement of mid-
QRS notching. Responders to CRT (CRT-R) were defined as patients with ≥15% reduction in left
ventricular end systolic volume after 6 months of CRT.
Results: Fifty-seven patients (70%) were CRT-R. QRSAREA was larger in CRT-R than in CRT non-
responders (140 ± 42 vs 100 ± 40 μVs, p b 0.001) and predicted CRT response better than QRS
duration (AUC 0.78 vs 0.62, p = 0.030). With a 98 μVs cutoff value, QRSAREA identified CRT-R
with an odds ratio (OR) of 10.2 and a 95% confidence interval (CI) of 3.4 to 31.1. This OR was
higher than that for QRS duration N156 ms (OR = 2.5; 95% CI 0.9 to 6.6), conventional LBBB
classification (OR = 5.5; 95% CI 0.9 to 32.4) or LBBB classification according to American
guidelines (OR = 4.5; 95% CI 1.6 to 12.6) or Strauss (OR = 10.0; 95% CI 3.2 to 31.1).
Conclusion: QRSAREA is an objective electrophysiological predictor of CRT response that performs
at least as good as the most refined definition of LBBB.
Condensed abstract: In 81 candidates for cardiac resynchronization therapy (CRT) we measured
the area of the QRS complex (QRSAREA) using 3-dimensional vectorcardiography. QRSAREA was
larger in echocardiographic responders than in non-responders and predicted CRT response better
than QRS duration and than simple LBBB criteria. QRSAREA is a promising electrophysiological
predictor of CRT response.
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sevier Inc. All rights reserved.conduction disturbances and persistent systolic heart failure
despite optimal medical therapy. By simultaneous stimula-
tion of the right (RV) and left (LV) ventricles the abnormal
ventricular activation is (partly) resynchronized. This
electrical resynchronization results in better LV pump
function and reverse ventricular remodeling on the long
term with a decrease in LV volumes, improving exercise
capacity, and reducing heart failure hospitalizations and
mortality [1,2].
Although the effects of CRT in large clinical trials are
impressive on a group level, benefits for the individual
patient vary considerably and are hard to predict. Up to half
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systolic volume (LVESV) and around 30% of patients do not
show clinical improvement [3]. Thus, to avoid invasive
procedures with the risk of complications and the unneces-
sary use of expensive products, a reliable tool for prediction
of responders to CRT is needed.
Many different strategies have been proposed, including
several echocardiographic parameters [4], but up to now the
ECG parameters QRS duration and QRS morphology are
most widely accepted [5–8], emphasizing the importance of a
good electrical substrate for this electrical therapy. Conse-
quently, American and European guidelines for clinical
decisionmaking to implant a CRT device have included these
electrical markers, i.e. QRS duration ≥150 ms with LBBB
morphology for class 1A recommendation [9,10]. However,
the definition of complete LBBB from the 12-lead ECG
varies and the most appropriate definition is still under debate
[11]. Recently, Strauss et al. [12] suggested to include the
presence of mid-QRS notching or slurring. Some of their
suggestions were subsequently incorporated in the American
guidelines for identification of LBBB [13]. Besides the
dissimilarity in how many and which leads should display
QRS notching or slurring, the classification of the presence of
“slurring” seems a subjective task.
We hypothesized that the QRS area (QRSAREA) from the
3-dimensional (3D) vectorcardiogram (VCG), which com-
bines QRS duration and electrical force of ventricular
activation, improves prediction of the response to CRT in
comparison to QRS duration on the ECG alone. Moreover,
QRSAREA is a continuous variable that is independent on the
specific definitions of LBBB.
To this purpose we compared the predictive power of
QRSAREA to the conventional electrical markers QRS duration
and morphology, the latter being specified using multiple
LBBB criteria, prospectively in a cohort of CRT patients.Materials and methods
Patients
Patients with heart failure scheduled for implantation of a
CRT device (CRT-P or CRT-D) at the Maastricht University
Hospital between September 2010 and June 2012
were prospectively approached to participate in this study
(n = 138). After exclusion of patients with previous RV
pacing (n = 22) or an intrinsic QRS duration b120 ms (n =
13), 103 patients were included. The study was performed
according to the principles of the Declaration of Helsinki and
approved by the ethics committee of Maastricht University
Hospital. All participants gave fully informed written
consent prior to investigation.
Study design
A standard 12-lead electrocardiogram (ECG) and a 3D-
VCG were recorded the day before CRT device implantation
with patients at rest and in supine position.
The ECG was recorded at a paper speed of 25 mm/s and a
scale of 10 mm/mV. QRS duration on the ECG was
determined using the automatic calculated value given bythe ECG equipment after confirmation of correctness. LBBB
was classified by a single investigator (CvD), who was
blinded to the echocardiographic outcome, according to
three different definitions.LBBB_1 QRS duration ≥130 ms, rS or QS pattern in
lead V1, absence of q-waves in V5–V6
(conventional criterion) [6].
LBBB_2 QRS duration ≥130 ms, rS or QS pattern in
lead V1, intrinsicoid deflection in lead
V6 ≥ 60 ms, mid-QRS notching or slurring in
2 or more contiguous leads of V1, V2, V5, V6, I
and aVL (according to Strauss et al. [12]).
LBBB_3 QRS duration ≥130 ms, rS or QS pattern in
lead V
1
, intrinsicoid deflection in lead
V6 ≥ 60 ms, broad notched or slurred R
wave in leads V5, V6, I as well as aVL
(according to American guidelines) [13].
The 3D-VCG was recorded the day before CRT device
implantation using 8 electrodes positioned according to the
modified Frank orthogonal lead system (X, Y and Z; Coronet
II System, Ortivus AB, Danderyd, Sweden) at a sampling
frequency of 500Hz for 5 minutes and averaged over one
minute. The VCGs were analyzed offline using customized
software [14]. The magnitude and direction of the maximum
QRS vector in space were expressed as amplitude (QRSAMPL;
mV), azimuth (angle in the transversal plane with backward
vector direction being negative; degrees) and elevation (angle
in craniocaudal direction with upward vector directions being
N90°; degrees). QRS-T angle is the 3D-angle between
maximum QRS and T vector in the preferential planes of the
QRS and T vector loops. The QRS area (QRSAREA; μVs) was
assessed as the “3D area” between the ventricular deflection
curve and the baseline from the beginning to the end of the
QRS complex (J-point) in X, Y and Z direction, and
calculated as (QRSx2 + QRSy2 + QRSz2)½; Fig. 1).
Ischemic etiology of heart failure was defined as presence
of delayed enhancement on cardiac magnetic resonance
imaging, irreversible perfusion defects on myocardial
thallium scans or untreated N70% stenosis in a coronary
artery according to coronary angiograms.
Echocardiography (iE33 systems, Philips Medical Sys-
tems, Best, the Netherlands) was performed the day before
device implantation as well as at follow up 6 months later.
CRT responders (CRT-R) and non-responders (CRT-NR)
were defined as patients with ≥15% and b15% reduction in
LVESV respectively, as determined using the biplane
method of disks (modified Simpson's method) after
6 months of CRT. In 26 patients the apical 2-chamber
view was of poor quality and volumetric response was
determined solely on the apical 4-chamber view.
Assessors of echocardiography and vectorcardiography
were blinded to the results from the other analyses.
Statistical analysis
Statistical analysis was performed using IBM SPSS
Statistics software version 20 (SPSS Inc, Chicago, Illinois)
Fig. 1. Upper: Calculation of the 3-dimensional QRS area (QRSAREA; μVs) using the integral between the ventricular deflection and the baseline from beginning
to the end of the QRS complex in X, Y and Z. Lower: Typical vector loops in the frontal and transversal planes and corresponding ECGs for a CRT non
responder (CRT-NR) and a CRT responder (CRT-R). Note the dominant QRS vector amplitude in the transversal plane for the CRT-R, generating a larger value
for QRSAREA as compared to the CRT-NR. Both patients were classified as having LBBB according to conventional criteria (LBBB_1), while none of them were
classified as having LBBB according to the more refined criteria (LBBB_2 or LBBB_3).
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bvba, Ostend, Belgium). Continuous variables were present-
ed as mean ± standard deviation (SD) or as median with
interquartile range [IQR] in case of non-normal distribution;
categorical variables as number (percentage). Linear corre-
lations between different predictors and change in LVESV
were evaluated by Pearson's correlation coefficient. Com-
parison between CRT-R and CRT-NR was performed by
Students' T-tests or Mann–Whitney U test as appropriate
(continuous variables) and χ2 test (categorical variables).
The classification performance of electrical parameters in
identifying CRT response was evaluated by receiver
operating characteristic (ROC) curve analysis. The signifi-
cance of the difference in classification performance between
parameters was evaluated by comparing the areas under the-ROC curve (AUC) with the method proposed by DeLong et
al. [15]. Continuous variables were dichotomized for
comparison with discrete parameters by computing cut-off
values with maximal sum of sensitivity and specificity.
Subsequently, odds ratios (OR), sensitivity, specificity,
positive predictive value (PPV) and negative predictive
values (NPV) were calculated for all parameters. Differences
were considered statistically significant at a two-sided
p-value of 0.05.Results
All patients underwent standard CRT device implantation
with an RV lead implanted most frequently in the RV apex
Table 1
Baseline characteristics of 81 patients receiving CRT.
Patient characteristics,






Age [years] 67 ± 9 68 ± 8 0.572
Gender M/F [%] 56/44 75/25 0.111
BMI [kg/m2] 28 ± 6 27 ± 5 0.981
Ischemic HF etiology [%] 39 75 0.003
Atrial fibrillation [%] 16 25 0.330
Diabetes mellitus [%] 35 21 0.205
6-MHWT [m] 409 ± 144 439 ± 136 0.506
NYHA class I/II/III/IV [%] 9/49/40/2 8/50/38/4 0.932
Minnesota [points] 33 ± 23 37 ± 26 0.646
eGFR [ml/min/1.73 m2] 70 ± 36 65 ± 32 0.589
NT-proBNP [mmol/l] 102 (31–230) 314 (82–472) 0.116
Hb [mmol/l] 8.4 ± 1.1 8.1 ± 1.0 0.311
LVEF [%] 26 ± 7 26 ± 6 0.766
LVEDV [ml] 191 ± 57 206 ± 63 0.297
IVMD [ms] 50 ± 18 38 ± 24 0.030
RV lead Ap/S [%] 96/4 100/0 0.353
LV lead A/AL/L/IL/I [%] 0/54/16/28/2 4/63/4/29/0 0.303
Medication
β-Blocker [%] 95 83 0.095
ACE-inhibitor/ARB [%] 88 88 0.978
Loop diuretics [%] 63 67 0.764
Ald-antagonist [%] 26 38 0.314
6-MHWT indicates six minute hall walking test; A, anterior; ACE,
angiotensin-converting enzyme; AL, anterolateral; Ald-antagonist, aldosterone
antagonist; Ap, apex; ARB, angiotensin II type 1 receptor blocker; BMI, body
mass index; CRT, cardiac resynchronization therapy; eGFR, estimated
glomerular filtration rate; F, female; Hb, hemoglobin; HF, heart failure; I,
inferior; IL, inferolateral; IVMD, interventricular mechanical delay; L, lateral;
LV, left ventricle; LVEF, left ventricular ejection fraction; LVEDV, left
ventricular end diastolic volume; M, male; RV, right ventricle; S, septum.
Table 2
Baseline ECG and VCG values in CRT responders and non-responders.
Predictors






QRS duration [ms] 161 ± 14 153 ± 18 0.035
LBBB_1 morphology 55 [97] 20 [83] 0.039
LBBB_2 morphology 50 [88] 10 [42] b0.001
LBBB_3 morphology 37 [65] 7 [29] 0.003
QRSAMPL [mV] 1.9 ± 0.6 1.5 ± 0.4 0.003
Azimuth [degrees] −64 ± 10 −64 ± 18 0.963
Elevation [degrees] 88 ± 17 94 ± 26 0.233
QRSAMPL_X [mV] 0.8 ± 0.4 0.6 ± 0.3 0.013
QRSAMPL_Y [mV] 0.1 ± 0.5 −0.1 ± 0.5 0.185
QRSAMPL_Z [mV] −1.7 ± 0.5 −1.2 ± 0.5 0.002
QRSAREA [ μVs] 140 ± 42 100 ± 40 b0.001
QRS-T angle [degrees] 166 ± 8 162 ± 14 0.163
CRT-NR indicates CRT non-responder; CRT-R, CRT responder; LBBB, left
bundle branch block; QRSAMPL, QRS vector amplitude; QRSAREA, QRS area.
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position with good stability, pacing thresholds and absence
of phrenic nerve stimulation. LV and RV lead positions were
determined by lateral and frontal chest radiographs; Table 1.
Optimization of stimulation intervals was performed accord-
ing to the attending cardiologists' decision.
After exclusion due to unsuccessful LV lead implantation
(n = 10), atrial fibrillation with b90% biventricular pacing at
follow-up (n = 2), missing echocardiographic evaluation at
6 months follow-up (n = 7), and impossible VCG
analyses due to technical disturbances or multiple ectopic
beats (n = 3), 81 patients were included for analyses.
Twenty-four patients (30%) were classified as CRT-NR.
Baseline characteristics did not differ between CRT-R and
CRT-NR except for ischemic etiology of heart failure which
was more common in the CRT-NR group and the
interventricular mechanical delay (IVMD) which was larger
in the CRT-R group (Table 1).
ECG and VCG parameters in responders and non-responders
Typical vector loops in the frontal and transversal planes
and corresponding ECGs for a CRT-NR and a CRT-R are
shown in Fig. 1. The narrow vector loops of the CRT-R were
characterized by a dominant vector amplitude in the
transversal plane, clearly pointing to the back of the patient.
Baseline QRS duration, QRSAMPL and QRSAREA were all
significantly larger in the CRT-R compared to the CRT-NRgroup, the difference between the groups being more
pronounced for the VCG parameters (Table 2, Fig. 2).
CRT-R patients fulfilled the morphology definitions to all
3 different LBBB criteria more frequently than CRT-NR
patients (Table 2). Almost all patients fulfilled the LBBB_1
definition (n = 75), whereas classification of LBBB_2 and
especially LBBB_3 definitions remained more selective
(n = 60 and n = 44 respectively).Correlation between ECG and VCG parameters and
volumetric CRT response
Using LVESV as a continuous variable, an inverse
correlation was observed between QRSAMPL or QRSAREA
and the percentage change in LVESV at 6 months of CRT
(r = −0.54 and r = −0.57 respectively). These correlations
were stronger than the correlation between QRS duration and
change in LVESV (r = −0.20; Fig. 2).Predictive value of ECG and VCG parameters for
CRT response
In Fig. 3, ROC curves are displayed, showing the abilities
of QRS duration, QRSAMPL and QRSAREA to predict CRT-
R. The area under the ROC curve was largest for QRSAREA
(AUC = 0.78), followed by QRSAMPL (AUC = 0.71) and
QRS duration (AUC = 0.62). The AUC for QRSAREA was
significantly larger than for QRS duration (p = 0.030),
indicating a more accurate prediction of CRT response.
Using a cutoff value for QRSAREA of 98 μVs, the odds ratio
for predicting CRT response was much higher (OR = 10.2;
95% confidence interval (CI) 3.4 to 31.1) than for QRS
duration N156 ms (OR = 2.5; 95% CI 0.9 to 6.6), LBBB_1
(OR = 5.5; 95% CI 0.9 to 32.4) and LBBB_3 (OR = 4.5;
95% CI 1.6 to 12.6), while LBBB_2 had a comparable OR
(OR = 10.0; 95% CI 3.2 to 31.1; Table 3).
QRS duration N156 ms falsely diagnosed 23 patients as
CRT-NR (60% sensitivity and 63% specificity; Table 4 and
Fig. 3). In comparison, QRSAREA N98 μVs only falsely
diagnosed 8 patients as CRT-NR (86% sensitivity and 63%
Fig. 2. Boxplots showing the median and interquartile range for QRS duration, QRSAMPL and QRSAREA between CRT-NR and CRT-R (upper panels) and the
relation between these variables and the relative change in left ventricular end systolic volume (LVESV) after 6 months of CRT (lower panels).
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predicting CRT-R was highest for QRSAREA N98 μVs.
QRSAREA in relation to other markers and different
patient characteristics
Fig. 4 shows plots of QRSAREA versus QRS duration. The
figure depicts that at a given QRS duration patients with aFig. 3. Receiver operating characteristics (ROC) curves for QRS duration
(dotted line), QRSAMPL (dashed line) and QRSAREA (straight line). Area
under the receiver operating curve (AUC) signifies performance of each
parameter in identifying CRT response and is given for each parameter with
the 95% confidence interval (CI).LBBB_2 morphology displayed larger QRSAREA compared
to those with non-LBBB_2 morphologies. Similarly, among
LBBB patients, QRSAREA was smaller in patients with an
ischemic etiology of heart failure compared to those with a
non-ischemic etiology. Furthermore, in patients with non-
LBBB and ischemic etiology of heart failure, QRS duration
may be prolonged without an increase in QRSAREA. Overall,
QRSAREA was significantly smaller in patients with an
ischemic etiology of heart failure (108 ± 39 μVs vs 148 ±
43 μVs, p b 0.001). QRSAREA was not significantly differ-
ent in males versus females (123 ± 43 μVs vs 137 ±
48 μVs, p = 0.183), and not related to age (r = −0.15,
p = 0.095) or BMI (r = −0.17, p = 0.060).
Discussion
The present prospective study demonstrates that the VCG
parameter QRSAREA predicts volumetric CRT response at
6 months better than QRS duration or the presence of
conventionally defined LBBB morphology. Moreover, the
predictive power of QRSAREA is comparable to that of the
most refined definition of LBBB, while it has the advantage
of being objectively quantifiable as a continuous parameter.
The predictive value of QRSAREA may be explained because
it appears to reflect both the presence of LBBB and the
etiology of heart failure.
QRSAREA as a predictor of response to CRT
Strong unopposed electrical forces, generated within the
heart, are the likely underlying mechanism of a large
QRSAREA. This is typically the case in dyssynchronous
ventricular activation like LBBB, where ventricular activa-
tion wavefronts propagate to the left and back of the patient
Table 4
Diagnostic performance of ECG and VCG parameters.
Predictors CRT-R Sensitivity Specificity PPV NPV
QRS duration N156 ms 60 63 79 39
LBBB_1 morphology 96 17 73 67
LBBB_2 morphology 88 58 83 67
LBBB_3 morphology 65 71 84 46
QRSAMPL N1.8 mV 56 75 84 42
QRSAREA N98 μVs 86 63 84 65
NPV indicates negative predictive value; PPV, positive predictive value.
Table 3
Univariate analysis of predictors of CRT response.
Predictors CRT-R Odds ratio 95% CI P-value
QRS duration N156 ms 2.5 0.9–6.6 0.072
LBBB_1 morphology 5.5 0.9–32.4 0.059
LBBB_2 morphology 10.0 3.2–31.1 b0.001
LBBB_3 morphology 4.5 1. 6–12.6 0.004
QRSAMPL N1.8 mV 3.8 1.3–11.1 0.013
QRSAREA N98 μVs 10.2 3.4–31.1 b0.001
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right and front of the patient [16]. This idea is supported by a
study demonstrating that a larger QRS integral obtained with
120-channel body surface imaging strongly correlated to the
presence of interventricular dyssynchrony obtained by
Doppler echocardiography [17]. However, these investiga-
tors found that there was no standard body surface ECG lead
to use for investigation of the QRS integral, because of
dependency on the mean electrical axis of the heart.
QRSAREA, which is the 3D-VCG QRS integral, can
overcome this problem, because it is independent of QRS
axis. According to a recent study using the same method-
ology as we employed, the average QRSAREA in healthy
adult subjects was found to be 34 μVs [18], a value of only
one third of that in LBBB. Moreover, several studies have
provided evidence that the more dyssynchronous the
baseline situation (especially LBBB), the better the substrate
for CRT [19,20].
On the other hand, QRSAREA is smaller in patients with an
ischemic etiology of heart failure and this etiology is known
to decrease the chance of response to CRT. The lower
QRSAREA in these hearts may be explained by the presence
of non-conducting fibrotic tissue which also decreases the
amount of tissue that can be recruited by CRT. Similarly, a
lower QRSAREA may arise from consequences of severe
hypertrophic remodeling such as electrical uncoupling
between cells as a consequence of fibrosis or deranged
expression or location of connexins [21]. These consider-
ations might explain the power of QRSAREA for prediction of
CRT response, but more research is required to better
understand all determinants of QRSAREA.QRSAREA is a stronger predictor of CRT response as
compared to QRS duration and LBBB morphology
In the present study, an optimal cutoff value for QRS
duration of N156 ms was calculated, close to the value used
in large clinical trials (150 ms) [5,7,8]. However, we found
that the power to predict CRT response was less than using
QRSAREA N98 μVs. This difference may be explained
because QRS duration only includes the time of depolari-
zation, while QRSAREA also reflects the electrical substrate
for CRT response, as discussed above [22].
Recently, several studies have already reported that a
LBBB morphology on the ECG is a stronger predictor of
CRT response than QRS duration [6–8] and this is now
incorporated in the current guidelines for class 1A
recommendation [9,10]. However, until now conventional
criteria for the definition of complete LBBB were used,which may include patients with a combination of LV
hypertrophy, LV enlargement and incomplete LBBB [23],
thus patients that possibly lack an ideal electrical substrate
for resynchronization therapy. In addition, none of the
conventional definitions have incorporated the presence of
mid-QRS notching or slurring in 2 or more contiguous leads
(V1, V2, V5, V6, I and aVL) as suggested by Strauss et al.
[12]. This refinement of the definition of LBBB morphology
has shown to significantly improve the performance of
predicting CRT response and clinical outcome as compared
to the conventional definition [24,25]. In the present study,
the use of a definition of LBBB that includes the presence of
mid-QRS notching or slurring according to Strauss et al.
appeared to be more accurate in predicting CRT response
than the presence of QRS notching or slurring according to
American guidelines or the conventional definition of
LBBB. However, the predictive power of even the most
refined LBBB definition was not better than having a
QRSAREA of N98 μVs. Though LBBB and QRSAREA
N98 μVs were strongly related to each other, the benefit of
using QRSAREA may be the objective measurement,
avoiding the subjective interpretation of presence of
notching or slurring and the dependence on correct ECG
lead positioning. Moreover, it provides a continuous
measurement, making it possible to adapt the cutoff value
according to the desired sensitivity and specificity. If an
almost 100% specificity is wanted (i.e. no non-responders), a
high cutoff value for QRSAREA should be applied.
Potential clinical implications
VCG is an easy and non-invasive technique. While we
used a dedicated 3D-VCG system in the present study, most
commercially available ECG machines have algorithms to
construct VCGs using the inverse Dower or Kors' regression
transformation [18,26]. From this, an automatic calculated
QRS area can be generated. However, the accuracy of the
inverse transformations has yet to be demonstrated for
patients with heart failure and wide QRS complex.
Furthermore, the present study emphasizes the importance
of including mid-QRS notching or slurring in the criteria for
LBBB, especially when present in 2 or more contiguous
leads of V1, V2, V5, V6, I and aVL.
Limitations
Although the number of patients included in this single
center study is modest and too small for subgroup analyses,
this is to our knowledge, the first study investigating 3D-
Fig. 4. QRSAREA plotted against QRS duration for patients without (left) and with (right) LBBB_2 morphology, and subdivided into presence of ischemic
etiology of heart failure (ICM; plus sign) or non-ischemic etiology of heart failure (NICM; hyphen). Regression lines are given for subgroups. Note that among
patients with non-LBBB and ICM, the QRS duration can prolong without an increase in QRSAREA. In LBBB patients, QRSAREA was smaller in patients with
ICM compared to those with NICM.
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Assessment of LBBB was performed by a single reviewer,
and an independent training and test set for the calculation of
a cutoff value for QRSAREA was lacking. Multicenter
prospective studies with a larger amount of patients are
required to confirm our results. These larger studies should
also search for confirmation of the predictive power of
QRSAREA with regard to clinical outcome, hospitalization
admissions and survival rate.
Conclusion
QRSAREA is a more powerful predictor of CRT response
compared to QRS duration or conventionally defined LBBB
morphology. Since it can be automatically computed, this
parameter can be easily applied in daily clinical practice,
thereby better identifying appropriate candidates for CRT
and potentially preventing ineffective, invasive and costly
CRT device implantations.
What is new?
- The best definition for predicting CRT response









, I and aVL.
- Such LBBB definition improves the selection of
patients that respond to CRT by a factor of 4 compared
to using QRS duration N 150 ms and by a factor 2 as
compared to conventional LBBB definitions.
- Selection of CRT candidates with good response is at
least as good with the objective and direction
insensitive QRSAREA, derived from the VCG.
- 3D VCG is a promising tool for better application
of CRT.
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